Chargement en cours...
ASSESSMENT OF ANTITUMOR ACTIVITY FOR TUMOR XENOGRAFT STUDIES USING EXPONENTIAL GROWTH MODELS
In preclinical tumor xenograft experiments, the antitumor activity of the tested agents is often assessed by endpoints such as tumor doubling time, tumor growth delay (TGD), and log10 cell kill (LCK). In tumor xenograft literature, the values of these endpoints are presented without any statistical...
Enregistré dans:
| Publié dans: | J Biopharm Stat |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4669107/ https://ncbi.nlm.nih.gov/pubmed/21442520 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10543406.2010.481802 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|